Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byambaa Enkhmaa

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Atherosclerosis|May 23, 2022
Non-genetic influences on lipoprotein(a) concentrationsByambaa Enkhmaa, Lars Berglund
Atherosclerosis|August 25, 2019
Statins and Lp(a): The plot thickensByambaa Enkhmaa, Lars Berglund
Journal of Internal Medicine|October 29, 2021
Lp(a) and SARS-CoV-2: A conspiracy of two mysteriesByambaa Enkhmaa, Lars Berglund
Translational Research : the Journal of Laboratory and Clinical Medicine|April 3, 2016
The unresolved mystery of high-density lipoprotein: time for a paradigm shift?Byambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund
Journal of Lipid Research|December 6, 2015
Lipoprotein (a): impact by ethnicity and environmental and medical conditionsByambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund
Translational Research : the Journal of Laboratory and Clinical Medicine|February 22, 2015
Mediterranean diet and cardiovascular disease: a step closer to mechanisms using a precision animal model?Byambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund
Clinical and Translational Science|December 21, 2010
Enigmatic role of lipoprotein(a) in cardiovascular diseaseErdembileg Anuurad, Byambaa Enkhmaa, Lars Berglund
Atherosclerosis|May 17, 2018
Non-HDL-C levels and residual cardiovascular risk: Do population-specific precision approaches offer any advantages?Byambaa Enkhmaa, Nishant Prakash, Lars Berglund
Current Diabetes Reports|April 29, 2010
Postprandial lipoproteins and cardiovascular disease risk in diabetes mellitusByambaa Enkhmaa, Zeynep Ozturk, Erdembileg Anuurad, et al.
Current Atherosclerosis Reports|November 4, 2016
Lipid Lowering with Soluble Dietary FiberPrasanth Surampudi, Byambaa Enkhmaa, Erdembileg Anuurad, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Atherosclerosis|May 23, 2022
Non-genetic influences on lipoprotein(a) concentrationsByambaa Enkhmaa, Lars Berglund
Atherosclerosis|August 25, 2019
Statins and Lp(a): The plot thickensByambaa Enkhmaa, Lars Berglund
Journal of Internal Medicine|October 29, 2021
Lp(a) and SARS-CoV-2: A conspiracy of two mysteriesByambaa Enkhmaa, Lars Berglund
Translational Research : the Journal of Laboratory and Clinical Medicine|April 3, 2016
The unresolved mystery of high-density lipoprotein: time for a paradigm shift?Byambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund
Journal of Lipid Research|December 6, 2015
Lipoprotein (a): impact by ethnicity and environmental and medical conditionsByambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund
Translational Research : the Journal of Laboratory and Clinical Medicine|February 22, 2015
Mediterranean diet and cardiovascular disease: a step closer to mechanisms using a precision animal model?Byambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund
Clinical and Translational Science|December 21, 2010
Enigmatic role of lipoprotein(a) in cardiovascular diseaseErdembileg Anuurad, Byambaa Enkhmaa, Lars Berglund
Atherosclerosis|May 17, 2018
Non-HDL-C levels and residual cardiovascular risk: Do population-specific precision approaches offer any advantages?Byambaa Enkhmaa, Nishant Prakash, Lars Berglund
Current Diabetes Reports|April 29, 2010
Postprandial lipoproteins and cardiovascular disease risk in diabetes mellitusByambaa Enkhmaa, Zeynep Ozturk, Erdembileg Anuurad, et al.
Current Atherosclerosis Reports|November 4, 2016
Lipid Lowering with Soluble Dietary FiberPrasanth Surampudi, Byambaa Enkhmaa, Erdembileg Anuurad, et al.
Pageof 6